Advocates Applaud DEA’s Fourth Extension of Remote Prescribing Flexibilities / MedCity

Marissa Plescia / medcitynews - The DEA extended telemedicine prescribing flexibilities for controlled substances through the end of 2026, drawing praise from telehealth advocates who are urging a permanent solution.The post Advocates Applaud DEA’s Fourth Extension of Remote Prescribing…

#healthcare #pharmaceuticals #publichealth #governmentpolicy

Matt Sherer: We Need a Permanent Solution for Telehealth Access

2 months / oncodaily

Why a waiver extension is crucial for the Rural Health Transformation Program

2 months / beckershospitalreview / Andrew Cass

Provider, telehealth groups urge Congress to make telehealth flexibilities permanent

2 months / healthcaredive / Emily Olsen

Another Extension Expected for Virtual Prescribing, Same Uncertainty

2 months / medcitynews / Thomas R. Milam

AMA to Congress: Make Medicare Telehealth Services Permanent

2 months / medcitynews / Marissa Plescia

DEA, HHS extend telehealth controlled substance prescribing flexibilities for fourth time

2 months / healthcaredive / Emily Olsen

Advocates Applaud DEA’s Fourth Extension of Remote Prescribing Flexibilities

2 months / medcitynews / Marissa Plescia

DEA issues fourth extension of telehealth controlled substance flexibilities as debate enters sixth year

2 months / fiercehealthcare

DEA extends telemedicine prescribing flexibilities through 2026

2 months / beckershospitalreview / Naomi Diaz

Friday, January 2, 2026, 6:22 pm / permalink 17439 / 9 stories in 2 months



Related Stories



Related Tags


Healthcare

EPA proposes rollback on ethylene oxide sterilizer emissions (6 min)

Two deaths prompt probe of paid plasma donation clinics in Winnipeg (1 hr)

HIMSS 2026 pushes real‑time data, cloud and interoperability playbook (18 hrs)

more #healthcare


Pharmaceuticals

Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma (19 hrs)

Atezolizumab added to chemoradiation fails to improve limited‑stage SCLC survival (22 hrs)

FDA approves leucovorin for rare folate disorder despite autism hype (34 hrs)

more #pharmaceuticals


Public Health

EPA proposes rollback on ethylene oxide sterilizer emissions (6 min)

Two deaths prompt probe of paid plasma donation clinics in Winnipeg (1 hr)

Vitamin D trial shows reduced long‑COVID risk but no severity benefit (21 hrs)

more #publichealth


StackHealth Time Machine



NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.